BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 20375583)

  • 21. c-Src mediates thrombin-induced NF-kappaB activation and IL-8/CXCL8 expression in lung epithelial cells.
    Lin CH; Cheng HW; Hsu MJ; Chen MC; Lin CC; Chen BC
    J Immunol; 2006 Sep; 177(5):3427-38. PubMed ID: 16920985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system.
    Barlow PG; Li Y; Wilkinson TS; Bowdish DM; Lau YE; Cosseau C; Haslett C; Simpson AJ; Hancock RE; Davidson DJ
    J Leukoc Biol; 2006 Sep; 80(3):509-20. PubMed ID: 16793910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of NF-kappa B in cytokine production induced from human airway epithelial cells by rhinovirus infection.
    Kim J; Sanders SP; Siekierski ES; Casolaro V; Proud D
    J Immunol; 2000 Sep; 165(6):3384-92. PubMed ID: 10975857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human cathelicidin production by the cervix.
    Frew L; Makieva S; McKinlay AT; McHugh BJ; Doust A; Norman JE; Davidson DJ; Stock SJ
    PLoS One; 2014; 9(8):e103434. PubMed ID: 25089904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs.
    Nijnik A; Pistolic J; Wyatt A; Tam S; Hancock RE
    J Immunol; 2009 Nov; 183(9):5788-98. PubMed ID: 19812202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF-kappaB-dependent induction of cathelicidin-related antimicrobial peptide in murine mast cells by lipopolysaccharide.
    Li G; Domenico J; Jia Y; Lucas JJ; Gelfand EW
    Int Arch Allergy Immunol; 2009; 150(2):122-32. PubMed ID: 19439978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure.
    Shaykhiev R; Beisswenger C; Kändler K; Senske J; Püchner A; Damm T; Behr J; Bals R
    Am J Physiol Lung Cell Mol Physiol; 2005 Nov; 289(5):L842-8. PubMed ID: 15964896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbial cell components induced tolerance to flagellin-stimulated inflammation through Toll-like receptor pathways in intestinal epithelial cells.
    Li N; Quidgley MC; Kobeissy FH; Joseph J; Neu J
    Cytokine; 2012 Dec; 60(3):806-11. PubMed ID: 22944462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease.
    Kusaka S; Nishida A; Takahashi K; Bamba S; Yasui H; Kawahara M; Inatomi O; Sugimoto M; Andoh A
    Clin Exp Immunol; 2018 Jan; 191(1):96-106. PubMed ID: 28872665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antimicrobial peptide LL-37 enhances IL-8 release by human airway smooth muscle cells.
    Zuyderduyn S; Ninaber DK; Hiemstra PS; Rabe KF
    J Allergy Clin Immunol; 2006 Jun; 117(6):1328-35. PubMed ID: 16750994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The roles of cathelicidin LL-37 in immune defences and novel clinical applications.
    Nijnik A; Hancock RE
    Curr Opin Hematol; 2009 Jan; 16(1):41-7. PubMed ID: 19068548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human cathelicidin LL-37 and its derivative IG-19 regulate interleukin-32-induced inflammation.
    Choi KY; Napper S; Mookherjee N
    Immunology; 2014 Sep; 143(1):68-80. PubMed ID: 24666281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fisetin inhibits the generation of inflammatory mediators in interleukin-1β-induced human lung epithelial cells by suppressing the NF-κB and ERK1/2 pathways.
    Peng HL; Huang WC; Cheng SC; Liou CJ
    Int Immunopharmacol; 2018 Jul; 60():202-210. PubMed ID: 29758489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Green tea polyphenol epigallocatechin-3-gallate and cranberry proanthocyanidins act in synergy with cathelicidin (LL-37) to reduce the LPS-induced inflammatory response in a three-dimensional co-culture model of gingival epithelial cells and fibroblasts.
    Lombardo Bedran TB; Palomari Spolidorio D; Grenier D
    Arch Oral Biol; 2015 Jun; 60(6):845-53. PubMed ID: 25791329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AGE-LDL activates Toll like receptor 4 pathway and promotes inflammatory cytokines production in renal tubular epithelial cells.
    Cheng A; Dong Y; Zhu F; Liu Y; Hou FF; Nie J
    Int J Biol Sci; 2013; 9(1):94-107. PubMed ID: 23355795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells.
    Huang F; Kao CY; Wachi S; Thai P; Ryu J; Wu R
    J Immunol; 2007 Nov; 179(10):6504-13. PubMed ID: 17982039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombin-induced IL-8/CXCL8 release is mediated by CK2, MSK1, and NF-κB pathways in human lung epithelial cells.
    Lin CH; Shih CH; Chen BC
    Eur J Pharmacol; 2015 Nov; 767():135-43. PubMed ID: 26463037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of toll-like receptor 7 and LL-37 expression in colon and breast epithelial cells by human beta-defensin-2.
    Stroinigg N; Srivastava MD
    Allergy Asthma Proc; 2005; 26(4):299-309. PubMed ID: 16270724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetramethylpyrazine Alleviates Tight Junction Disruption of Bronchial Mucosal Epithelial Cells Caused by Interleukin-17 via Inhibiting Nuclear Factor-κB-p65/Tumor Necrosis Factor-α Signaling Pathway.
    Lin X; Zhu Y; Le G
    J Interferon Cytokine Res; 2021 Nov; 41(11):415-424. PubMed ID: 34698528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The human Cathelicidin LL-37 induces MUC5AC mucin production by airway epithelial cells via TACE-TGF-α-EGFR pathway.
    Zhang Y; Zhu M; Yang Z; Pan X; Jiang Y; Sun C; Wang Q; Xiao W
    Exp Lung Res; 2014 Sep; 40(7):333-42. PubMed ID: 24901072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.